Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2010

01.04.2010 | Research Article

Appropriateness of timing of drug administration in electronic prescriptions

verfasst von: Arwa Hassan, Walter E. Haefeli

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction For a small number of drugs circadian variability has been shown to modify efficacy, safety, or pharmacokinetics. Objective of the study We aimed to develop a database containing optimum timing of drug administration and to test how well such information is considered in daily practice. Setting University hospital providing primary and tertiary care. Methods We included data of randomised controlled trials collected from Embase and Medline studying the impact of the timing of drug administration on pharmacodynamics, pharmacokinetics, and adverse events. Data were analysed and weighed according to an algorithm considering trial design and assessed endpoints. Each branch of the algorithm led to a specific recommendation as to the time of the day the drug should be administered. A second algorithm was used to establish a recommendation if studies differed in their conclusion. Subsequently we retrospectively analysed the dosing time in consecutive electronic prescriptions issued at our institution in 2007. Results For 30 active compounds randomised controlled trials were published assessing optimum timing of their administration. In 33% of them timing had no impact on clinical endpoints while the administration at a certain time of the day significantly improved the outcome of another 64% no clear statement was made for one drug (ketoprofen). We then analysed 478864 electronic prescriptions. Two percent of them contained drugs with known circadian variability. Only in 14% the suggested time was considered with a range between 0% for telmisartan (bedtime administration) and 85% for perindopril (morning administration). Conclusion Thus far, dedicated studies on circadian responsiveness to drugs are sparse and for the few drugs with unequivocal evidence this information is only rarely considered in daily practice. Integration of circadian dosing information into a clinical decision support system linked to electronic prescribing may be one promising way to make this information widely accessible.
Literatur
1.
Zurück zum Zitat Smolensky MH, Portaluppi F. Chronopharmacology and chronotherapy of cardiovascular medications relevance to prevention and treatment of coronary heart disease. Am Heart J. 1999;137:14–24.CrossRef Smolensky MH, Portaluppi F. Chronopharmacology and chronotherapy of cardiovascular medications relevance to prevention and treatment of coronary heart disease. Am Heart J. 1999;137:14–24.CrossRef
2.
Zurück zum Zitat Lemmer B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 1996;33:107–15.CrossRefPubMed Lemmer B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 1996;33:107–15.CrossRefPubMed
3.
Zurück zum Zitat Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987;93:515–8.PubMed Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987;93:515–8.PubMed
4.
Zurück zum Zitat Lemmer B, Nold G. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol. 1991;32:627–9.PubMed Lemmer B, Nold G. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol. 1991;32:627–9.PubMed
5.
Zurück zum Zitat Shaw GL, Falk RT, Caporaso NE, Issaq HJ, Kase RG, Fox SD, et al. Effect of diurnal variation on debrisoquine metabolic phenotyping. J Natl Cancer Inst. 1990;82:1573–5.CrossRefPubMed Shaw GL, Falk RT, Caporaso NE, Issaq HJ, Kase RG, Fox SD, et al. Effect of diurnal variation on debrisoquine metabolic phenotyping. J Natl Cancer Inst. 1990;82:1573–5.CrossRefPubMed
6.
Zurück zum Zitat Bleyzac N, Allard-Latour B, Laffont A, Mouret J, Jelliffe R, Maire P. Diurnal changes in the pharmacokinetic behavior of amikacin. Ther Drug Monit. 2000;22:307–12.CrossRefPubMed Bleyzac N, Allard-Latour B, Laffont A, Mouret J, Jelliffe R, Maire P. Diurnal changes in the pharmacokinetic behavior of amikacin. Ther Drug Monit. 2000;22:307–12.CrossRefPubMed
7.
Zurück zum Zitat Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous. J Cardiovasc Pharmacol. 2004;43:68–73.CrossRefPubMed Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous. J Cardiovasc Pharmacol. 2004;43:68–73.CrossRefPubMed
8.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, et al. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2007;24:471–93.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, et al. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2007;24:471–93.CrossRefPubMed
9.
Zurück zum Zitat White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12:806–14.CrossRefPubMed White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12:806–14.CrossRefPubMed
10.
Zurück zum Zitat Usher RW, Beasley CM Jr, Bosomworth JC. Efficacy and safety of morning versus evening fluoxetine administration. J Clin Psychiatry. 1991;52:134–6.PubMed Usher RW, Beasley CM Jr, Bosomworth JC. Efficacy and safety of morning versus evening fluoxetine administration. J Clin Psychiatry. 1991;52:134–6.PubMed
11.
Zurück zum Zitat Vashi V, Chung M, Dias N, Phillips K. Effect of time of administration on the pharmacokinetics and tolerance of doxazosin in healthy male volunteers. J Clin Pharmacol. 1996;36:325–31.PubMed Vashi V, Chung M, Dias N, Phillips K. Effect of time of administration on the pharmacokinetics and tolerance of doxazosin in healthy male volunteers. J Clin Pharmacol. 1996;36:325–31.PubMed
12.
Zurück zum Zitat Kirby RS, Chapple CR, Sethia K, Flannigan M, Milroy EJ, Abrams P. Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safety. Prostate Cancer Prostatic Dis. 1998;1:163–71.CrossRefPubMed Kirby RS, Chapple CR, Sethia K, Flannigan M, Milroy EJ, Abrams P. Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safety. Prostate Cancer Prostatic Dis. 1998;1:163–71.CrossRefPubMed
13.
Zurück zum Zitat Khasawneh SM, Affarah HB. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing. Am J Gastroenterol. 1992;87:1180–2.PubMed Khasawneh SM, Affarah HB. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing. Am J Gastroenterol. 1992;87:1180–2.PubMed
14.
Zurück zum Zitat Hongo M, Ohara S, Hirasawa Y, Abe S, Asaki S, Toyota T. Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing. Dig Dis Sci. 1992;37:882–90.CrossRefPubMed Hongo M, Ohara S, Hirasawa Y, Abe S, Asaki S, Toyota T. Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing. Dig Dis Sci. 1992;37:882–90.CrossRefPubMed
15.
Zurück zum Zitat Scharnagl H, Vogel M, Abletshauser C, Freisinger F, Stojakovic T, März W. Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration. Cardiology. 2006;106:241–8.CrossRefPubMed Scharnagl H, Vogel M, Abletshauser C, Freisinger F, Stojakovic T, März W. Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration. Cardiology. 2006;106:241–8.CrossRefPubMed
16.
Zurück zum Zitat Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. Evening vs. morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol. 1993;35:51–4.PubMed Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. Evening vs. morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol. 1993;35:51–4.PubMed
17.
Zurück zum Zitat Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27:15–20.CrossRefPubMed Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27:15–20.CrossRefPubMed
18.
Zurück zum Zitat Postma DS, Sevette C, Martinat Y, Schlösser N, Aumann J, Kafé H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J. 2001;17:1083–8.CrossRefPubMed Postma DS, Sevette C, Martinat Y, Schlösser N, Aumann J, Kafé H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J. 2001;17:1083–8.CrossRefPubMed
19.
Zurück zum Zitat Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997;80:421–5.CrossRefPubMed Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997;80:421–5.CrossRefPubMed
20.
Zurück zum Zitat Glass-Marmor L, Paperna T, Galboiz Y, Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol. 2009;210:124–7.CrossRefPubMed Glass-Marmor L, Paperna T, Galboiz Y, Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol. 2009;210:124–7.CrossRefPubMed
21.
Zurück zum Zitat Lund TM, Torsvik H, Falch D, Christophersen B, Skårdal R, Gullestad L. Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. Am J Cardiol. 2002;90:784–6.CrossRefPubMed Lund TM, Torsvik H, Falch D, Christophersen B, Skårdal R, Gullestad L. Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. Am J Cardiol. 2002;90:784–6.CrossRefPubMed
22.
Zurück zum Zitat Wallace A, Chinn D, Rubin G. Taking simvastatin in the morning compared with in the evening: randomised controlled trial. BMJ. 2003;327:788.CrossRefPubMed Wallace A, Chinn D, Rubin G. Taking simvastatin in the morning compared with in the evening: randomised controlled trial. BMJ. 2003;327:788.CrossRefPubMed
23.
Zurück zum Zitat Pehlivanov ND, Olyaee M, Sarosiek I, McCallum RW. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Aliment Pharmacol Ther. 2003;18:883–90.CrossRefPubMed Pehlivanov ND, Olyaee M, Sarosiek I, McCallum RW. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Aliment Pharmacol Ther. 2003;18:883–90.CrossRefPubMed
24.
Zurück zum Zitat Kerr DJ, Lewis C, O’Neil B, Lawson N, Blackie RG, Newell DR, et al. The myelotoxicity of carboplatin is influenced by the time of its administration. Hematol Oncol. 1990;8:59–63.CrossRefPubMed Kerr DJ, Lewis C, O’Neil B, Lawson N, Blackie RG, Newell DR, et al. The myelotoxicity of carboplatin is influenced by the time of its administration. Hematol Oncol. 1990;8:59–63.CrossRefPubMed
25.
Zurück zum Zitat Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther. 1992;52:378–83.PubMed Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther. 1992;52:378–83.PubMed
26.
Zurück zum Zitat Levi F, Le Louarn C, Reinberg A. Timing optimizes sustained-release indomethacin treatment of osteoarthritis. Clin Pharmacol Ther. 1985;37:77–84.PubMed Levi F, Le Louarn C, Reinberg A. Timing optimizes sustained-release indomethacin treatment of osteoarthritis. Clin Pharmacol Ther. 1985;37:77–84.PubMed
27.
Zurück zum Zitat Ozaydin M, Dede O, Dogan A, Aslan SM, Altinbas A, Ozturk M, et al. Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention. Am J Cardiol. 2006;97:44–7.CrossRefPubMed Ozaydin M, Dede O, Dogan A, Aslan SM, Altinbas A, Ozturk M, et al. Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention. Am J Cardiol. 2006;97:44–7.CrossRefPubMed
28.
Zurück zum Zitat Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ. Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol. 1996;36:604–9.PubMed Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ. Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol. 1996;36:604–9.PubMed
29.
Zurück zum Zitat Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719–26.CrossRefPubMed Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719–26.CrossRefPubMed
30.
Zurück zum Zitat Busse WW, Bush RK. Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma. Am J Med. 1985;79:62–6.CrossRefPubMed Busse WW, Bush RK. Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma. Am J Med. 1985;79:62–6.CrossRefPubMed
31.
Zurück zum Zitat Su YM, Cheng TP, Yeh TW, Wen CY, Wang DI. Influence of morning or evening administration on absorption of theophylline. Zhonghua Yi Xue Za Zhi. 2000;63:113–8.PubMed Su YM, Cheng TP, Yeh TW, Wen CY, Wang DI. Influence of morning or evening administration on absorption of theophylline. Zhonghua Yi Xue Za Zhi. 2000;63:113–8.PubMed
32.
Zurück zum Zitat Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998;3:17–25.PubMed Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998;3:17–25.PubMed
33.
Zurück zum Zitat Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther. 2003;17:335–41.CrossRefPubMed Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther. 2003;17:335–41.CrossRefPubMed
34.
Zurück zum Zitat Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J. 1992;123:1307–11.CrossRefPubMed Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J. 1992;123:1307–11.CrossRefPubMed
35.
Zurück zum Zitat Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205–11.CrossRefPubMed Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205–11.CrossRefPubMed
36.
Zurück zum Zitat Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology. 1985;88:64–9.PubMed Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology. 1985;88:64–9.PubMed
37.
Zurück zum Zitat Müssig S, Witzel L, Lühmann R, Schneider A. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH. Eur J Gastroenterol Hepatol. 1997;9:599–602.PubMed Müssig S, Witzel L, Lühmann R, Schneider A. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH. Eur J Gastroenterol Hepatol. 1997;9:599–602.PubMed
38.
Zurück zum Zitat Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Rodríguez M, et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 2005;46:1060–8.CrossRefPubMed Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Rodríguez M, et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 2005;46:1060–8.CrossRefPubMed
39.
Zurück zum Zitat Moore JG, Goo RH. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol Int. 1987;4:111–6.CrossRefPubMed Moore JG, Goo RH. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol Int. 1987;4:111–6.CrossRefPubMed
40.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–90.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–90.CrossRefPubMed
41.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–22.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–22.CrossRefPubMed
42.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Mojón A, Rodríguez M, Chayán L, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int. 2005;22:755–76.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, Mojón A, Rodríguez M, Chayán L, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int. 2005;22:755–76.CrossRefPubMed
43.
Zurück zum Zitat Hermida RC, Ayala DE, Fernández JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 2007;50:715–22.CrossRefPubMed Hermida RC, Ayala DE, Fernández JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 2007;50:715–22.CrossRefPubMed
44.
Zurück zum Zitat Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 2009;26:61–79.CrossRefPubMed Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 2009;26:61–79.CrossRefPubMed
45.
Zurück zum Zitat Myburgh DP, Verho M, Botes JH, Erasmus TP, Luus HG. 24-Hour blood pressure control with ramipril: comparison of once-daily morning and evening administration. Current Ther Res. 1995;56:1298–306.CrossRef Myburgh DP, Verho M, Botes JH, Erasmus TP, Luus HG. 24-Hour blood pressure control with ramipril: comparison of once-daily morning and evening administration. Current Ther Res. 1995;56:1298–306.CrossRef
46.
Zurück zum Zitat Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54:40–6.CrossRefPubMed Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54:40–6.CrossRefPubMed
47.
Zurück zum Zitat Calvo C, Hermida RC, Ayala DE, López JE, Rodríguez M, Chayán L, et al. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin. 2006;127:721–9.CrossRef Calvo C, Hermida RC, Ayala DE, López JE, Rodríguez M, Chayán L, et al. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin. 2006;127:721–9.CrossRef
48.
Zurück zum Zitat Reinberg A, Gervais P, Chaussade M, Fraboulet G, Duburque B. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol. 1983;71:425–33.CrossRefPubMed Reinberg A, Gervais P, Chaussade M, Fraboulet G, Duburque B. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol. 1983;71:425–33.CrossRefPubMed
49.
Zurück zum Zitat Vinje O, Fagertun HE, Laerum E, Lund H, Larsen S. Ketoprofen controlled release (CR) in the treatment of osteoarthrosis; a double blind, randomized multicentre study of single morning versus evening dose. Norwegian Study Group of General Practitioners. Scand J Prim Health Care. 1993;11:91–7.CrossRefPubMed Vinje O, Fagertun HE, Laerum E, Lund H, Larsen S. Ketoprofen controlled release (CR) in the treatment of osteoarthrosis; a double blind, randomized multicentre study of single morning versus evening dose. Norwegian Study Group of General Practitioners. Scand J Prim Health Care. 1993;11:91–7.CrossRefPubMed
50.
Zurück zum Zitat Perpoint B, Mismetti P, Simitsidis S, Hocquart J, Rambaud C, Buchmuller A, et al. Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis. Chronobiol Int. 1994;11:119–25.CrossRefPubMed Perpoint B, Mismetti P, Simitsidis S, Hocquart J, Rambaud C, Buchmuller A, et al. Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis. Chronobiol Int. 1994;11:119–25.CrossRefPubMed
51.
Zurück zum Zitat Poondru S, Devaraj R, Boinpally RR, Yamasani MR. Chronopharmacokinetics of sumatriptan in healthy human subjects. J Pharm Pharmacol. 2000;52:1085–90.CrossRefPubMed Poondru S, Devaraj R, Boinpally RR, Yamasani MR. Chronopharmacokinetics of sumatriptan in healthy human subjects. J Pharm Pharmacol. 2000;52:1085–90.CrossRefPubMed
52.
Zurück zum Zitat Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300:2514–26.CrossRefPubMed Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300:2514–26.CrossRefPubMed
Metadaten
Titel
Appropriateness of timing of drug administration in electronic prescriptions
verfasst von
Arwa Hassan
Walter E. Haefeli
Publikationsdatum
01.04.2010
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2010
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9362-4

Weitere Artikel der Ausgabe 2/2010

International Journal of Clinical Pharmacy 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.